Healthcare

L-HPC/NBD

Multifunctional excipient for oral solid dose

L-HPC/NBD
L-HPC is a non-ionic multi-functional excipient

L-HPC (low-substituted hydroxypropyl cellulose NF, JP, EP) was developed by Shin-Etsu and first approved in 1977 as a disintegrant for tablets in Japan. New grades were developed during the last years in order to cover the needs for our customer having best solutions for individual applications.

 

As example, LH-B1 was launched in 2002, a non fibrous grade, recommended as dispersing aid for capsule filling. In addition to the conventional grades (LH-), NBD- grades which have improved characteristics such as particle shape and compressibility were introduced in 2011.

History of L-HPC

Structure of L-HPC

L-HPC is a non-ionic multi-functional excipient based on a cellulose backbone combined with a low amount of hydroxypropopyl groups.

 

Thus, L-HPC is not soluble in water but showing swelling properties in this media.
Typical applications of L-HPC are anti-capping for tableting process, binder and disintegrant, stability enhancer of solid dosage forms. Several grades are available (see the table below) depending on the final application, focusing on the most common oral dosage forms: tablets, pellets and capsules.

L-HPC Marken

MarkenBeschreibungRegulatorischHerkunftKnowledge Base
LH-1150 µm, 11 % HPONF, EP, JPJapan Auswählen
Zugehörige DokumenteSprachenVerfügbar als Download oder Anfrage
Brochures
Guide to Applications
L-HPC
LAB Poster Tablet defects
Pharmaceutical Excipients
Safety Data Sheets
Safety Data Sheet
Technical Information
Application of L-HPC and PHARMACOAT® in twin screw granulation for continuous manufacturing [L-039]
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
Change of swelling performance of disintegrants after wet granulation [L-031]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - hydroxypropyl content [L-020]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - internal addition and particle attributes [L-021]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - particle attributes [L-019]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - roller compaction [L-022]
Differences in wet granulation (WG) processing using L-HPC - internal vs external addition [L-012]
Effect of L-HPC in the Drug Layering application [L-042]
Effect of the added water quantity to the tablet properties at wet granulation process with L-HPC [L-014]
Influence of tablet shape on capping tendency [L-032]
Interaction with L-HPC and vitamins [L-038]
Minitablets using L-HPC [L-024]
Pellet extrusion - spheronizazion using L-HPC [L-011]
Pellets preparation by drug layering using L-HPC [L-015]
Rapid release from hard capsules using L-HPC as a filler [L-009]
Roller compaction using L-HPC - influence of re-processing [L-010]
Suitability of L-HPC and PHARAMCOAT® in twin screw granulation: significance and synergistic effect [L-040]
The effect of a glidant on L-HPC [L-029]
The effect of a glidant on L-HPC for dry granulation [L-030]
Twin screw granulation using L-HPC [L-028]
Water absorption of L-HPC [L-041]
Water binding capability of L-HPC in wet granulation [L-018]
LH-21. 2245 µm, 8-11 % HPONF, EP, JPJapan Auswählen
Zugehörige DokumenteSprachenVerfügbar als Download oder Anfrage
Brochures
Guide to Applications
L-HPC
Pharmaceutical Excipients
Safety Data Sheets
Safety Data Sheet
Technical Information
Application of L-HPC and PHARMACOAT® in twin screw granulation for continuous manufacturing [L-039]
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
Change of swelling performance of disintegrants after wet granulation [L-031]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - hydroxypropyl content [L-020]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - internal addition and particle attributes [L-021]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - particle attributes [L-019]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - roller compaction [L-022]
Differences in wet granulation (WG) processing using L-HPC - internal vs external addition [L-012]
Effect of the added water quantity to the tablet properties at wet granulation process with L-HPC [L-014]
Influence of tablet shape on capping tendency [L-032]
Interaction with L-HPC and vitamins [L-038]
Minitablets using L-HPC [L-024]
Pellet extrusion - spheronizazion using L-HPC [L-011]
Pellets preparation by drug layering using L-HPC [L-015]
Rapid release from hard capsules using L-HPC as a filler [L-009]
Roller compaction using L-HPC - influence of re-processing [L-010]
Suitability of L-HPC and PHARAMCOAT® in twin screw granulation: significance and synergistic effect [L-040]
The effect of a glidant on L-HPC [L-029]
The effect of a glidant on L-HPC for dry granulation [L-030]
Twin screw granulation using L-HPC [L-028]
Water absorption of L-HPC [L-041]
Water binding capability of L-HPC in wet granulation [L-018]
LH-B150 µm, 11 % HPONF, EP, JPJapan Auswählen
Zugehörige DokumenteSprachenVerfügbar als Download oder Anfrage
Brochures
Guide to Applications
L-HPC
Pharmaceutical Excipients
Safety Data Sheets
Safety Data Sheet
Technical Information
Application of L-HPC and PHARMACOAT® in twin screw granulation for continuous manufacturing [L-039]
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
Change of swelling performance of disintegrants after wet granulation [L-031]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - hydroxypropyl content [L-020]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - internal addition and particle attributes [L-021]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - particle attributes [L-019]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - roller compaction [L-022]
Differences in wet granulation (WG) processing using L-HPC - internal vs external addition [L-012]
Effect of the added water quantity to the tablet properties at wet granulation process with L-HPC [L-014]
Influence of tablet shape on capping tendency [L-032]
Interaction with L-HPC and vitamins [L-038]
Minitablets using L-HPC [L-024]
Pellet extrusion - spheronizazion using L-HPC [L-011]
Pellets preparation by drug layering using L-HPC [L-015]
Rapid release from hard capsules using L-HPC as a filler [L-009]
Roller compaction using L-HPC - influence of re-processing [L-010]
Suitability of L-HPC and PHARAMCOAT® in twin screw granulation: significance and synergistic effect [L-040]
The effect of a glidant on L-HPC [L-029]
The effect of a glidant on L-HPC for dry granulation [L-030]
Twin screw granulation using L-HPC [L-028]
Water absorption of L-HPC [L-041]
Water binding capability of L-HPC in wet granulation [L-018]
LH-31. 3220 µm, 8-11 % HPONF, EP, JPJapan Auswählen
Zugehörige DokumenteSprachenVerfügbar als Download oder Anfrage
Brochures
Guide to Applications
L-HPC
Pharmaceutical Excipients
Safety Data Sheets
Safety Data Sheet
Technical Information
Application of L-HPC and PHARMACOAT® in twin screw granulation for continuous manufacturing [L-039]
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
Change of swelling performance of disintegrants after wet granulation [L-031]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - hydroxypropyl content [L-020]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - internal addition and particle attributes [L-021]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - particle attributes [L-019]
Comparative study of various L-HPC for Paracetamol 500 mg tablets - roller compaction [L-022]
Differences in wet granulation (WG) processing using L-HPC - internal vs external addition [L-012]
Effect of the added water quantity to the tablet properties at wet granulation process with L-HPC [L-014]
Influence of tablet shape on capping tendency [L-032]
Interaction with L-HPC and vitamins [L-038]
Minitablets using L-HPC [L-024]
Pellet extrusion - spheronizazion using L-HPC [L-011]
Pellets preparation by drug layering using L-HPC [L-015]
Rapid release from hard capsules using L-HPC as a filler [L-009]
Roller compaction using L-HPC - influence of re-processing [L-010]
Suitability of L-HPC and PHARAMCOAT® in twin screw granulation: significance and synergistic effect [L-040]
The effect of a glidant on L-HPC [L-029]
The effect of a glidant on L-HPC for dry granulation [L-030]
Twin screw granulation using L-HPC [L-028]
Water absorption of L-HPC [L-041]
Water binding capability of L-HPC in wet granulation [L-018]
NBD-02045 µm, 14 % HPONF, EP, JPJapan Auswählen
Zugehörige DokumenteSprachenVerfügbar als Download oder Anfrage
Brochures
Guide to Applications
L-HPC
Pharmaceutical Excipients
Safety Data Sheets
Safety Data Sheet
Technical Information
Orally disintegrating tablets using L-HPC (NBD Grades) [L-016]
Super-high speed direct compression using L-HPC NBD [L-027]
NBD-02145 µm, 11 % HPONF, EP, JPJapan Auswählen
Zugehörige DokumenteSprachenVerfügbar als Download oder Anfrage
Brochures
Guide to Applications
L-HPC
Pharmaceutical Excipients
Safety Data Sheets
Safety Data Sheet
Technical Information
Orally disintegrating tablets using L-HPC (NBD Grades) [L-016]
Super-high speed direct compression using L-HPC NBD [L-027]
NBD-02245 µm, 8 % HPONF, EP, JPJapan Auswählen
Zugehörige DokumenteSprachenVerfügbar als Download oder Anfrage
Brochures
Guide to Applications
L-HPC
Pharmaceutical Excipients
Safety Data Sheets
Safety Data Sheet
Technical Information
Orally disintegrating tablets using L-HPC (NBD Grades) [L-016]
Super-high speed direct compression using L-HPC NBD [L-027]

Benefits and Applications of L-HPC

L-HPC used in immediate release tablets contributes to the optimisation of the formulations and can be seen as a problem solver. One of the benefits of L-HPC is linked to its non-ionic nature and absence of peroxide leading to a better stability of the drugs by avoiding interactions with active pharmaceutical ingredients (API).

Another advantage linked to its particle size and shape is to resolve “capping” issues, which is a typical problem in the tableting process. Several reports have highlighted that capping is caused by a high residual die-wall pressure during the tableting process. L-HPC reduces the residual die-wall force and ejection force during the tableting process.

Looking at the functionalities of the L-HPC in terms of swelling and especially the optimized compressibility of the NBD grades, it can simplify immediate release tablets formulation as only one excipient is needed to assure good tablet hardness and quick disintegration. Thus L-HPC is a key excipient for reducing the tablet size as it is the case for mini-tablets. Besides the direct compression, in case of poor powder flowability or low active content, a granulation step is needed to improve the flow of the tabletting mass.

L-HPC can be used during the wet or the dry granulation process. Roller compaction is a dry granulation technique. The powder blend requires sufficient binding to form a stable ribbon and larger granules with less fine powders after the milling step. L-HPC NBD-grades increase the binding properties of the roller compaction formulation. At the same time L-HPC acts as disintegrant ensuring the quick disintegration of the roller compacted immediate release formulation.

As well as tableting, L-HPC is also applicable for pellet extrusion. Micronized grades (typically LH-31) are best suited for this application because smaller particles can easily pass through the screen. L-HPC provides wet mass with a “buffer effect” where the wet mass accepts a wider range of water content. L-HPC plasticizes wet mass and shows greater productivity (extrusion speed and yield). The final pellets show quick disintegration and better friability compared with non-L-HPC formulations.

For the capsule filling, the swelling property of L-HPC will actively contribute to improve the disintegration and dissolution of the cake formed during the capsule filling process. L-HPC has 9 variations in physical and chemical properties and can be used for different application. In order to know which grade is more suitable for your application check our guide of application in the table below.

Marken und Anwendungen

Anwendungen
 
Tabletten und Pellets
Anti-capping
Dissolution improvement for wet granulation (WG)
Disintegration improvement for wet granulation (WG)
Binding for wet granulation (WG)
Disintegration improvement for direct compression (DC)
Binding for DC
Binding for roller compaction (RC)
Pellet extrusion
Dissolution improvement from drug layer
Orally disintegrating tablets (ODT)
Kapseln
Dispersing Aid for capsule filling
Tabletten und Pellets
Dispersible tablets
Continuous Manufacturing (CM) for Oral Solid Dosage Form (OSD)
Wet granulation (WG) immediate release (IR)
Roller compaction (RC) immediate release (IR)
Direct compression (DC) immediate release (IR)
Capsule filling
L-HPC
LH-11LH-21. 22LH-B1LH-31. 32NBD-020NBD-021NBD-022
             
••        
  ••        
    ••        
••   ••
        ••
    •• •• ••
      •• •• ••
    ••      
      ••    
      ••
             
  ••      
             
           
             
•• •• •• ••
•• ••
•• •• ••
    ••   •• ••

• Geeignet / •• Sehr geeignet

Technical Information regarding L-HPC

Shin-Etsu has more than 40 Technical documents available for L-HPC; such as:

More information on the applications of L-HPC can be found here.

High Quality with Shin-Etsu

The Shin-Etsu team is supporting in all technical, quality and regulatory related questions. Our team of sales and technical sales manager can help you to develop your products, or provide support during issues at your manufacturing process. Shin-Etsu has long year experience in cellulose ether business and is aiming to give you the best possible guidance and high quality products manufactured in Japan and Germany.

You can get in contact with us through:

 

contactnoSpam@setylose.com

METOLOSE®

Next product:

METOLOSE®

Water soluble cellulose ethers

Read more